- Cytokine Programming Combined with 4-1BB Enrichment Enhances Ovarian TIL Expansion and Function 2260346
Paramita Chakraborty et al. · The Journal of Immunology · 2026
- Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer
Mark S. Shahin et al. · Gynecologic Oncology · 2026
- It's not just a number: Age at diagnosis varies by molecular subtype in endometrial cancer
Sydney Oesch et al. · Gynecologic Oncology · 2026
- Patient-reported outcomes from the final analysis of the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: Results from the homologous recombination-deficient (HRd) and -proficient (HRp) populations
Floor Jenniskens Backes et al. · Gynecologic Oncology · 2026
- ENTPD1 in ovarian cancer: An immune thermostat responsible for “cold” tumors, poor outcomes, and racial disparities. (A Deep South Consortium in Oncology Project)
Kaitlyn Cedoz et al. · Gynecologic Oncology · 2026
- Correlates of Serum Concentrations of Biomarkers Relevant to Ovarian Cancer Screening
Maxwell Akonde et al. · The Journal of Applied Laboratory Medicine · 2026
- Patient Perceptions of a Financial Resource Handout Following Gynecologic Cancer Diagnosis: A Mixed-Methods Study of Feasibility and Patient-Reported Utility
Arielle R Levine et al. · Cureus · 2026
- Rezatapopt, a selective p53 reactivator, in advanced or metastatic solid tumours with a TP53 Y220C mutation: interim efficacy results from patients with ovarian cancer in the phase 2 PYNNACLE trial
Jean‐Sébastien Frenel et al. · International Journal of Gynecological Cancer · 2026
- The cervical cancer divide: state variation in incidence, mortality, and progress toward elimination in the United States
Trisha L. Amboree et al. · JNCI Cancer Spectrum · 2026
- A Case Report of Pancreatic Oligometastasis of Uterine Leiomyosarcoma
Anne Cambrelin et al. · Case Reports in Oncological Medicine · 2026